Literature DB >> 19276543

A novel Italian presenilin 2 gene mutation with prevalent behavioral phenotype.

Gabriella Marcon1, Giuseppe Di Fede, Giorgio Giaccone, Giacomina Rossi, Anna Rita Giovagnoli, Elio Maccagnano, Fabrizio Tagliavini.   

Abstract

Presenilin mutations are the main cause of familial Alzheimer's disease. So far, more than 160 mutations in the Presenilin 1 gene (PSEN1) and approximately 10 mutations in the homologous Presenilin 2 gene (PSEN2) have been identified. Some PSEN1 mutations are associated with a phenotype fulfilling the clinical criteria of frontotemporal dementia. In PSEN2, T122P and M239V mutations presented with severe behavioral disturbances. We describe an Italian patient with a novel PSEN2 mutation (Y231C) who showed behavioral abnormalities and language impairment as presenting symptoms, with later involvement of other cognitive abilities, particularly of posterior functions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276543     DOI: 10.3233/JAD-2009-0986

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  13 in total

1.  Alzheimer's disease phenotypes and genotypes associated with mutations in presenilin 2.

Authors:  Suman Jayadev; James B Leverenz; Ellen Steinbart; Justin Stahl; William Klunk; Cheng-En Yu; Thomas D Bird
Journal:  Brain       Date:  2010-04       Impact factor: 13.501

Review 2.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

3.  Genetic pathway-based hierarchical clustering analysis of older adults with cognitive complaints and amnestic mild cognitive impairment using clinical and neuroimaging phenotypes.

Authors:  Chantel D Sloan; Li Shen; John D West; Heather A Wishart; Laura A Flashman; Laura A Rabin; Robert B Santulli; Stephen J Guerin; C Harker Rhodes; Gregory J Tsongalis; Thomas W McAllister; Tim A Ahles; Stephen L Lee; Jason H Moore; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-07       Impact factor: 3.568

4.  Presenilin 2 mutation R71W in an Italian early-onset sporadic Alzheimer's disease case.

Authors:  Paola Piscopo; Giuseppina Talarico; Lorenzo Malvezzi-Campeggi; Alessio Crestini; Roberto Rivabene; Marina Gasparini; Giuseppe Tosto; Nicola Vanacore; Gian Luigi Lenzi; Giuseppe Bruno; Annamaria Confaloni
Journal:  J Neurol       Date:  2011-05-05       Impact factor: 4.849

5.  Familial frontotemporal dementia-associated presenilin-1 c.548G>T mutation causes decreased mRNA expression and reduced presenilin function in knock-in mice.

Authors:  Hirotaka Watanabe; Dan Xia; Takahisa Kanekiyo; Raymond J Kelleher; Jie Shen
Journal:  J Neurosci       Date:  2012-04-11       Impact factor: 6.167

Review 6.  Cerebral amyloidosis: amyloid subunits, mutants and phenotypes.

Authors:  A Rostagno; J L Holton; T Lashley; T Revesz; Jorge Ghiso
Journal:  Cell Mol Life Sci       Date:  2009-11-07       Impact factor: 9.261

7.  Rare variants in APP, PSEN1 and PSEN2 increase risk for AD in late-onset Alzheimer's disease families.

Authors:  Carlos Cruchaga; Gabe Haller; Sumitra Chakraverty; Kevin Mayo; Francesco L M Vallania; Robi D Mitra; Kelley Faber; Jennifer Williamson; Tom Bird; Ramon Diaz-Arrastia; Tatiana M Foroud; Bradley F Boeve; Neill R Graff-Radford; Pamela St Jean; Michael Lawson; Margaret G Ehm; Richard Mayeux; Alison M Goate
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

8.  PSEN2 Mutation Spectrum and Novel Functionally Validated Mutations in Alzheimer's Disease: Data from PUMCH Dementia Cohort.

Authors:  Liling Dong; Caiyan Liu; Longze Sha; Chenhui Mao; Jie Li; Xinying Huang; Jie Wang; Shanshan Chu; Bin Peng; Liying Cui; Qi Xu; Jing Gao
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 9.  Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders.

Authors:  Yan Cai; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2015-07-14       Impact factor: 4.458

10.  Probable novel PSEN2 Val214Leu mutation in Alzheimer's disease supported by structural prediction.

Authors:  Young Chul Youn; Eva Bagyinszky; HyeRyoun Kim; Byung-Ok Choi; Seong Soo An; SangYun Kim
Journal:  BMC Neurol       Date:  2014-05-15       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.